Lexicon Pharmaceuticals LXRX Total Operating Expenses
Discontinued — last reported Q1 '23
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 4, 2023, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's total operating expenses?
- Lexicon Pharmaceuticals (LXRX) reported total operating expenses of -$31.17M in Q1 2023.
- How has Lexicon Pharmaceuticals's total operating expenses changed year-over-year?
- Lexicon Pharmaceuticals's total operating expenses decreased by 233.1% year-over-year, from $23.42M to -$31.17M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.